CMNDClearmind Medicine Inc.

Nasdaq clearmindmedicine.com


$ 1.65 $ -0.07 (-4.09 %)    

Friday, 19-Jul-2024 15:58:08 EDT
QQQ $ 475.02 $ -4.25 (-0.89 %)
DIA $ 402.92 $ -3.77 (-0.93 %)
SPY $ 548.99 $ -3.67 (-0.66 %)
TLT $ 92.97 $ -0.55 (-0.59 %)
GLD $ 221.79 $ -4.05 (-1.79 %)
$ 1.64
$ 1.66
$ 1.64 x 400
$ 1.67 x 400
$ 1.60 - $ 1.67
$ 0.92 - $ 16.19
676,574
na
996,033
$ -0.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clearmind-medicine-inks-pact-to-source-manufacturers-and-distributors-for-its-alcohol-substitute-beverage-product

This partnership aims to source global manufacturers and distributors for Clearmind's groundbreaking MEAI-based alcohol sub...

 clearmind-medicine-granted-patent-approval-in-hong-kong-for-its-binge-behaviors-treatment

- Reuters 

 why-psychedelic-pharma-clearmind-medicine-stock-is-moving-higher

Clearmind Medicine shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge...

 whats-going-on-with-clearmind-medicine-stock-tuesday

Clearmind said its alcohol substitute was granted patents in the U.S., India and Europe. The company also highlighted that the ...

Core News & Articles
Market-Moving News for June 11th
06/11/2024 12:29:09

MOLN: 11% | Molecular Partners shares are trading higher after the company announced the debut of their lead Raido-DARPin thera...

 clearmind-medicine-announces-advancement-in-its-proprietary--meai--based-alcohol-substitute-beverage-program

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

 clearmind-medicine-advances-meai-based-alcohol-substitute-beverage-program

The global market of no- and low-alcohol beverages estimated at over $13 billion in 2023

 why-clearmind-medicine-stock-is-moving-higher

Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yis...

Core News & Articles
Market-Moving News for May 7th
05/07/2024 12:36:21

CMND: 60% | Clearmind Medicine shares are trading higher after the company signed an exclusive patent licensing agreement with ...